Efficacy and Safety of Niraparib as First-Line Maintenance Treatment for Patients with Advanced Ovarian Cancer: Real-World Data from a Multicenter Study in China.
Zhao M, Qiu S, Wu X, Miao P, Jiang Z, Zhu T, Xu X, Zhu Y, Zhang B, Yuan D, Zhang Y, Sun W, He A, Zhao M, Hou W, Zhang Y, Shao Z, Jia M, Li M, Chen J, Xu J, Chen B, Zhou Y, Shen Y.
Zhao M, et al. Among authors: jia m.
Target Oncol. 2023 Nov;18(6):869-883. doi: 10.1007/s11523-023-00999-x. Epub 2023 Oct 17.
Target Oncol. 2023.
PMID: 37847485
Free PMC article.